The Vanguard High Dividend Yield ETF maintains a Hold rating amid a dramatically widened yield gap versus Treasuries. Read ...
ArriVent BioPharma’s Phase 3 lung cancer trial was clouded by stronger-than-expected data for patients receiving chemotherapy, prompting analysts to pivot focus to a late-stage test of the tyrosine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results